CONMED Corporation (CNMD): Price and Financial Metrics


CONMED Corporation (CNMD): $80.17

-1.82 (-2.22%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

CNMD POWR Grades

  • CNMD scores best on the Growth dimension, with a Growth rank ahead of 92.69% of US stocks.
  • CNMD's strongest trending metric is Quality; it's been moving down over the last 177 days.
  • CNMD ranks lowest in Sentiment; there it ranks in the 11th percentile.

CNMD Stock Summary

  • CNMD's went public 32.53 years ago, making it older than 85.55% of listed US stocks we're tracking.
  • Price to trailing twelve month operating cash flow for CNMD is currently 32.8, higher than 86.83% of US stocks with positive operating cash flow.
  • Over the past twelve months, CNMD has reported earnings growth of -102.32%, putting it ahead of just 15.23% of US stocks in our set.
  • Stocks that are quantitatively similar to CNMD, based on their financial statements, market capitalization, and price volatility, are ASUR, REZI, TRVG, PTPI, and LXFR.
  • Visit CNMD's SEC page to see the company's official filings. To visit the company's web site, go to www.conmed.com.

CNMD Valuation Summary

  • In comparison to the median Healthcare stock, CNMD's price/earnings ratio is 212.24% lower, now standing at -22.
  • Over the past 243 months, CNMD's price/earnings ratio has gone down 40.8.

Below are key valuation metrics over time for CNMD.

Stock Date P/S P/B P/E EV/EBIT
CNMD 2022-09-23 2.4 3.7 -22.0 -1485.8
CNMD 2022-09-22 2.4 3.8 -22.3 -1501.0
CNMD 2022-09-21 2.5 3.9 -23.1 -1543.5
CNMD 2022-09-20 2.6 4.0 -23.6 -1569.3
CNMD 2022-09-19 2.6 4.0 -23.9 -1580.8
CNMD 2022-09-16 2.7 4.1 -24.5 -1609.7

CNMD Growth Metrics

    Its 5 year cash and equivalents growth rate is now at -9.79%.
  • Its 3 year cash and equivalents growth rate is now at 6.22%.
  • Its year over year net income to common stockholders growth rate is now at 403.03%.
CNMD's revenue has moved up $230,424,000 over the prior 52 months.

The table below shows CNMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-06-30 1,042.314 74.217 -113.924
2022-03-31 1,020.285 89.754 67.657
2021-12-31 1,010.635 111.77 62.542
2021-09-30 989.493 98.13 62.238
2021-06-30 978.501 111.894 54.14
2021-03-31 881.125 83.154 13.45

CNMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • CNMD has a Quality Grade of C, ranking ahead of 54.31% of graded US stocks.
  • CNMD's asset turnover comes in at 0.564 -- ranking 77th of 186 Medical Equipment stocks.
  • OSUR, MMSI, and BSX are the stocks whose asset turnover ratios are most correlated with CNMD.

The table below shows CNMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.564 0.554 0.083
2021-06-30 0.559 0.551 0.086
2021-03-31 0.506 0.533 0.045
2020-12-31 0.495 0.534 0.038
2020-09-30 0.500 0.534 0.041
2020-06-30 0.497 0.532 0.033

CNMD Stock Price Chart Interactive Chart >

Price chart for CNMD

CNMD Price/Volume Stats

Current price $80.17 52-week high $159.11
Prev. close $81.99 52-week low $77.09
Day low $80.02 Volume 393,100
Day high $83.66 Avg. volume 363,213
50-day MA $93.83 Dividend yield 1%
200-day MA $119.02 Market Cap 2.44B

CONMED Corporation (CNMD) Company Bio


CONMED Corporation is a medical technology company that provides surgical devices and equipment for minimally invasive procedures. The Company's products are used by surgeons and physicians in a variety of specialties, including orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company was founded in 1970 and is based in Utica, New York.


CNMD Latest News Stream


Event/Time News Detail
Loading, please wait...

CNMD Latest Social Stream


Loading social stream, please wait...

View Full CNMD Social Stream

Latest CNMD News From Around the Web

Below are the latest news stories about CONMED CORP that investors may wish to consider to help them evaluate CNMD as an investment opportunity.

3 Reasons to Retain CONMED (CNMD) Stock in Your Portfolio

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

Yahoo | September 28, 2022

CONMED Corporation to Participate in a Fireside Chat at the Morgan Stanley Global Healthcare Conference

LARGO, Fla., September 06, 2022--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a fireside chat at the 20th Annual Morgan Stanley Global Healthcare Conference at 5:15 p.m. ET on Tuesday, September 13, 2022.

Yahoo | September 6, 2022

PDCO vs. CNMD: Which Stock Is the Better Value Option?

PDCO vs. CNMD: Which Stock Is the Better Value Option?

Yahoo | August 22, 2022

CONMED (NYSE:CNMD) Is Paying Out A Dividend Of $0.20

CONMED Corporation ( NYSE:CNMD ) has announced that it will pay a dividend of $0.20 per share on the 5th of October...

Yahoo | August 18, 2022

CONMED Corporation Announces Quarterly Cash Dividend

LARGO, Fla., August 11, 2022--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2022 to all shareholders of record as of September 15, 2022.

Yahoo | August 11, 2022

Read More 'CNMD' Stories Here

CNMD Price Returns

1-mo -8.34%
3-mo -17.08%
6-mo -44.98%
1-year -39.56%
3-year -12.03%
5-year 56.29%
YTD -43.13%
2021 27.35%
2020 1.16%
2019 75.71%
2018 27.39%
2017 17.33%

CNMD Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full CNMD Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.506 seconds.